TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Bio-Works Sweden AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
25,465
|
43,896
|
41,373 |
| Financial expenses |
9
|
2
|
20 |
| Earnings before taxes |
-35,215
|
-51,993
|
-41,793 |
| EBITDA |
-34,916
|
-52,243
|
-42,160 |
| Total assets |
21,927
|
24,581
|
41,655 |
| Current assets |
20,110
|
22,092
|
39,222 |
| Current liabilities |
7,254
|
15,581
|
21,354 |
| Equity capital |
14,673
|
9,000
|
20,301 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
31
|
33
|
35 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
66.9%
|
36.6%
|
48.7% |
| Turnover per employee |
821
|
1,330
|
1,182 |
| Profit as a percentage of turnover |
-138.3%
|
-118.4%
|
-101.0% |
| Return on assets (ROA) |
-160.6%
|
-211.5%
|
-100.3% |
| Current ratio |
277.2%
|
141.8%
|
183.7% |
| Return on equity (ROE) |
-240.0%
|
-577.7%
|
-205.9% |
| Change turnover |
-18,431
|
2,523
|
19,410 |
| Change turnover % |
-42%
|
6%
|
88% |
| Chg. No. of employees |
-2
|
-2
|
8 |
| Chg. No. of employees % |
-6%
|
-6%
|
30% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.